TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. AMENDMENT NO. FOUR TO LICENSE AND COMMERCIALIZATION AGREEMENT This AMENDMENT NO. FOUR...License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
Contract Type FiledMarch 16th, 2006 Company Industry Jurisdiction
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. AMENDMENT NO. THREE TO LICENSE AND COMMERCIALIZATION AGREEMENT This AMENDMENT NO....License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations
Contract Type FiledMarch 16th, 2006 Company Industry
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. LICENSE AND COMMERCIALIZATION AGREEMENT BY AND BETWEENLicense and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
Contract Type FiledMarch 16th, 2006 Company Industry Jurisdiction
BY AND AMONGLicense and Commercialization Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2004 Company Industry Jurisdiction
BY AND AMONGLicense and Commercialization Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 15th, 2003 Company Industry Jurisdiction